Control Bionics Limited

CBL

AU0000114183

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. Other stock markets 23:41:16 2024-05-09 EDT			5-day change	1st Jan Change
0.05 ^AUD	+2.04%		+16.28%	+8.70%

05-09	Control Bionics Appoints CFO	MT
05-08	Control Bionics Signs Multiple Award Schedule Contract with US Government	MT

Control Bionics Limited Announces Unaudited Sales Results for the Month Ended May 2023

June 13, 2023 at 02:10 am

Control Bionics Limited announced unaudited sales results for the month ended May 2023. The group invoiced a total of AUD 692,000 of sales for the month, the highest month of invoices for 2023.

Latest news about Control Bionics Limited

Control Bionics Appoints CFO	05-08	MT
Control Bionics Signs Multiple Award Schedule Contract with US Government	05-08	MT
Australian Shares Jump to More than Three-Week High as Central Bank Holds Rates	05-07	MT
Control Bionics Signs MoU for Japan Launch of NeuroStrip; Shares Up 13%	05-07	MT
Control Bionics Registers Wearable Device with UK Medical Regulator	03-07	MT
Control Bionics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-27	CI
Control Bionics Secures US Grant Funding to Develop Autonomous Wheelchair Device	01-23	MT
Control Bionics Raises AU$1 Million Via Shortfall Placement	01-18	MT
Control Bionics Receives AU$480,500 R&D Tax Rebate	11-21	MT
Control Bionics Launches NeuroStrip Wearable Device	23-10-12	MT
Control Bionics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-30	CI
Control Bionics Limited Provides Revenue Guidance for the Year Ended 30 June 2023	23-06-13	CI
Control Bionics Limited Announces Unaudited Sales Results for the Month Ended May 2023	23-06-13	CI
Control Bionics Limited Announces Directorate Changes	23-05-03	CI
Control Bionics Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-23	CI
Investments in Indonesia's nickel industry	23-02-06	RE
Control Bionics Limited Announces Board Changes	23-01-18	CI
Control Bionics Limited Announces CEO Changes	23-01-18	CI
6,933,538 Options of Control Bionics Limited are subject to a Lock-Up Agreement Ending on 7-DEC-2022.	22-12-06	CI
42,818,796 Ordinary Shares of Control Bionics Limited are subject to a Lock-Up Agreement Ending on 7-DEC-2022.	22-12-06	CI
Control Bionics CEO Resigns	22-09-14	MT
Control Bionics Limited Announces Resignation of Rob Wong as CEO	22-09-14	CI
Control Bionics Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-24	CI
Control Bionics Limited Auditor Raises 'Going Concern' Doubt	22-08-23	CI
Control Bionics Declares Fiscal Q4, FY22 Cash Receipts	22-07-27	MT

Control Bionics Limited is a medical device company engaged in the development, commercialization and sale of assistive communications technology systems within the disability sector. It assists patients whose ability to communicate verbally or through text and social media is compromised by illnesses, such as motor neuron disease, amyotrophic lateral sclerosis, and others. Its NeuroNode technology is a wireless wearable device that detects minute signals sent from the brain to any skeletal muscle and is captured as Electromyography output. This output is then sent wirelessly through the NeuroNode to a personal computer, enabling speech and other computer-controlled functions, such as email and texting. Its core systems include NeuroNode Trilogy, NeuroNode Duo, Eye-gaze Duo, and DROVE. Its technology is integrated with eye-gaze technology, whereby the eye gaze enables a cursor to be moved on a computer screen, driven like a mouse, and the NeuroNode acts like the mouse button.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-20 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
CONTROL BIONICS LIMITED	+8.70%	5.63M
QUIDELORTHO CORPORATION	-42.18%	2.85B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+22.02%	1.94B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	+0.39%	1.68B
BIOTAGE AB	+27.15%	1.26B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-10.70%	1.03B
CONTEC MEDICAL SYSTEMS CO.,LTD	-18.27%	938M
REVENIO GROUP OYJ	+0.66%	783M
VAREX IMAGING CORPORATION	-25.07%	628M
CELLAVISION AB	+14.62%	535M

Medical Diagnostic & Testing Equipment